Skip to main content

Table 1 Baseline characteristics of 133 HIV-positive subjects from the SHCS and 5328 HIV-negative subjects from the AMIS registry at the time of their first myocardial infarction

From: Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study

 

SHCS

AMIS registry

 
 

HIV-positive subjects

HIV-negative subjects

 
 

Total

 

Total

 

P_values a

Age, year

133

51 (46–57)

5328

64 (55–74)

<0.0001

Men

133

113 (85.0)

5328

3845 (72.2)

0.001

Weight (kg)

121

71 (63–71)

5167

78 (69–88)

<0.0001

Height (cm)

133

174 (169–178)

4803

171 (165–176)

0.0003

Body Mass Index (kg/m 2 )

121

23. (21.6–26.1)

4801

26.5 (24.2–29.4)

<0.0001

Blood pressure

     

Systolic (mmHg)

119

132 (120–149)

5273

140 (120–160)

0.0034

Diastolic (mmHg)

119

75 (83–90)

5270

81 (71–94)

0.9015

Other cardiovascular risk factors

     

Smoking history

132

 

5094

 

<0.0001

- Active smokers

 

77 (58.3)

 

2009 (39.4)

 

- Former smokers

 

23 (17.5)

 

1311 (25.7)

 

- Non smokers

 

32 (24.2)

 

1774 (34.8)

 

Family history of CAD b

133

18 (13.5)

4717

1571 (33.3)

<0.0001

Hypertension

133

32 (24.1)

5323

3231 (60.7)

<0.0001

Diabetes mellitus

133

18 (13.5)

4734

739 (15.6)

0.569

Biological parameters

     

Glycemia (mmol/l)

116

5.3 (4.7–6.0)

4920

7.1 (6.1–8.8)

<0.0001

Total cholesterol (mmol/l)

120

5.4 (4.5–6.3)

4078

5.4 (4.6–6.2)

0.952

HDL cholesterol (mmol/l)

120

1.1 (0.9–1.3)

3720

1.2 (1.0–1.5)

0.005

Serum creatinine (umol/l)

121

80 (69–93)

5158

81 (69–94)

0.779

Discharge AMI diagnosis

110

 

5328

 

0.025

STEMI

 

53 (48.2)

 

3135 (58.8)

 

NSTEMI

 

57 (51.8)

 

2193 (41.2)

 

Current cardiovascular treatments

     

Platelets inhibitor recipients

133

120 (90.2)

5326

5169 (97.0)

<0.0001

Antihypertensive drugs

133

107 (80.5)

5327

4735 (88.9)

0.002

Lipid lowering drugs

133

115 (86.5)

5325

5028 (94.4)

<0.0001

  1. Data are no. (%) of subjects or median (interquartile range).
  2. aWilcoxon rank-sum test for quantitative variables and chi square test for qualitative variable bCAD: coronary artery disease.